Controlling silk fibroin particle features for drug delivery.
about
The Potential of Silk and Silk-Like Proteins as Natural Mucoadhesive Biopolymers for Controlled Drug DeliveryBiosafe nanoscale pharmaceutical adjuvant materialsSilk fibroin-based nanoparticles for drug deliveryProcessing Techniques and Applications of Silk Hydrogels in BioengineeringThe Encapsulation of Hemagglutinin in Protein Bodies Achieves a Stronger Immune Response in Mice than the Soluble AntigenChemically cross-linked silk fibroin hydrogel with enhanced elastic properties, biodegradability, and biocompatibilityBovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear.Novel flower-shaped albumin particles as controlled-release carriers for drugs to penetrate the round-window membrane.Charge-Tunable Silk-Tropoelastin Protein Alloys That Control Neuron Cell Responses.Reversible hydrogel-solution system of silk with high beta-sheet content.Biomaterials derived from silk-tropoelastin protein systemsIncorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug releaseUnravelling the biodiversity of nanoscale signatures of spider silk fibres.Silk as an innovative biomaterial for cancer therapySynthesis, cellular uptake, and biodistribution of whey-rich nanoparticles.The influence of elasticity and surface roughness on myogenic and osteogenic-differentiation of cells on silk-elastin biomaterials.Natural and Genetically Engineered Proteins for Tissue Engineering.Effects of pH on the silk fibroin coating of CoCrMo alloy.Multifunctional silk-tropoelastin biomaterial systemsSilk self-assembly mechanisms and control from thermodynamics to kinetics.Folic acid-conjugated soybean protein-based nanoparticles mediate efficient antitumor ability in vitro.Silk-based stabilization of biomacromolecules.Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cellsBiopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Designing silk-silk protein alloy materials for biomedical applications.The method of purifying bioengineered spider silk determines the silk sphere properties.Silk constructs for delivery of musculoskeletal therapeutics.pH-dependent anticancer drug release from silk nanoparticles.Natural Non-Mulberry Silk Nanoparticles for Potential-Controlled Drug Release.A Review of Structure Construction of Silk Fibroin Biomaterials from Single Structures to Multi-Level Structures.Characteristics of platelet gels combined with silk.Silk fibroin biomaterials for controlled release drug delivery.Controlled release from recombinant polymersFunctionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.The future perspectives of natural materials for pulmonary drug delivery and lung tissue engineering.A quicker degradation rate is yielded by a novel kind of transgenic silk fibroin consisting of shortened silk fibroin heavy chains fused with matrix metalloproteinase cleavage sites.Novel fabrication method of the peritoneal dialysis filter using silk fibroin with urease fixation system.Preparation of silk fibroin carriers for controlled release.Properties of Engineered and Fabricated Silks.A pilot study of macrophage responses to silk fibroin particles.
P2860
Q26774443-8AE2A56A-8D88-4F06-A640-CC6BE3B96BB2Q26829798-708EBDB3-9B06-46EB-8630-9ADFD8676724Q26995026-549CF90D-94FC-4AB4-A33A-99A85765F3FEQ28070885-D8DFDC8E-902A-49B8-9A0D-1399C4CA9979Q28387068-F6CC866E-B169-4C43-B9CB-ABBB0153D04FQ28828744-E180CD39-6B73-465C-A83B-6E30DC6A2B1FQ30433180-9336A315-40AF-4ABF-8609-AF9A501E94C9Q30434310-AD8CF68B-0D5F-49CE-8101-4C66E75DC790Q33988574-774F6D0F-CE92-4697-BEC0-3C3EB1FA07D1Q34033759-FBBD51F1-DABB-4134-9264-F07BD89D79B5Q34106425-886C1F49-D52A-40AF-B1D3-9157A713CBD7Q34349134-AB72E89A-7933-4CB5-969E-A1AB50102498Q35068881-75471A2F-E7D7-4153-9467-480EE8E9358EQ35113124-FA784596-342F-42F5-9DB4-DD4B523D52C4Q35161889-CA0C9F60-0474-4466-8BEC-B28AF0E0D177Q35502693-50142AD3-8FF7-4C1E-8C0A-03D1EC3D3A9EQ35516528-003A42D4-590E-4B23-8BD9-9DCD094D9EF8Q35630721-DF407D83-CD9E-4A60-BC80-29C2301CF275Q35636597-04901E98-A772-4F0B-AD6E-3CDDA5C4C83EQ35827702-C54B82D2-1C79-4302-BA17-4C2979F39B1FQ36203093-D5C7A78E-BB49-4DAF-AA13-83E2B686A78BQ36307700-1E427CDA-B26C-43FF-8697-85A6782B6E26Q36412713-F04A7643-D0E8-4226-898E-E55A57027EC3Q36590092-709ADCA4-B88F-4725-96D4-2B12B5F541F6Q36826606-D6B8171F-042B-46EC-8F85-BCCF0464244AQ37014900-791EADCF-920B-4573-97CF-1D5E080838DEQ37035579-108BF2F9-0B4A-46C4-BD09-1003B4C16BAAQ37255777-7B8909FE-A1D1-4BE4-8294-F3A5F1777184Q37534610-AA7F7466-7441-48C5-93FD-CC8E149C5B88Q37728967-8E38023A-5725-42A1-A455-0C7E07E665FEQ37732239-E709CB45-769C-4DC3-A8C1-680FB203A01FQ37859773-DEE2C2E6-51F5-4265-81AF-0AFE4A46CD98Q38222535-95B4473F-CBDD-45E7-A88F-B38B16C837EDQ38287775-8BDF0CF1-65D6-4864-BF46-322F2E693F0FQ38293299-51A075EC-6A87-48F1-80CF-D68C83C2C7B2Q38307320-1EC46A6E-7C72-421E-AA2A-4FCF4196BA5BQ38412554-B1A51A9F-D4DA-4D17-B4C4-AB095AAE4B31Q38659751-8D35929B-A261-43F3-978B-F0CC7F55C3F5Q39094624-F3C542C2-327A-4035-B8E8-26D1B956A273Q39229391-CA1016F7-6EFC-4455-B414-9C2BC26A9E3C
P2860
Controlling silk fibroin particle features for drug delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Controlling silk fibroin particle features for drug delivery.
@en
Controlling silk fibroin particle features for drug delivery.
@nl
type
label
Controlling silk fibroin particle features for drug delivery.
@en
Controlling silk fibroin particle features for drug delivery.
@nl
prefLabel
Controlling silk fibroin particle features for drug delivery.
@en
Controlling silk fibroin particle features for drug delivery.
@nl
P2860
P50
P1433
P1476
Controlling silk fibroin particle features for drug delivery
@en
P2093
Andreas S Lammel
Sang-Hyug Park
P2860
P304
P356
10.1016/J.BIOMATERIALS.2010.02.024
P577
2010-03-09T00:00:00Z